M3, Inc. Share Price OTC Markets

Equities

MTHRY

US55379N1063

Internet Services

Market Closed - OTC Markets 20:47:26 25/06/2024 BST 5-day change 1st Jan Change
4.74 USD +1.50% Intraday chart for M3, Inc. +1.72% -42.27%

Financials

Sales 2024 239B 1.49B 118B Sales 2025 * 266B 1.66B 131B Capitalization 1,040B 6.49B 513B
Net income 2024 45.27B 283M 22.33B Net income 2025 * 47.65B 298M 23.5B EV / Sales 2024 5.49 x
Net cash position 2024 139B 870M 68.74B Net cash position 2025 * 152B 952M 75.19B EV / Sales 2025 * 3.34 x
P/E ratio 2024
32 x
P/E ratio 2025 *
21.8 x
Employees 10,533
Yield 2024
0.98%
Yield 2025 *
1.47%
Free-Float 60.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.50%
1 week+1.72%
Current month-1.46%
1 month-3.66%
3 months-31.80%
6 months-40.45%
Current year-42.27%
More quotes
1 week
4.52
Extreme 4.5201
4.77
1 month
4.52
Extreme 4.5201
5.36
Current year
4.52
Extreme 4.5201
8.78
1 year
4.52
Extreme 4.5201
11.90
3 years
4.52
Extreme 4.5201
41.49
5 years
4.52
Extreme 4.5201
52.42
10 years
4.52
Extreme 4.5201
52.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 28/09/00
Director/Board Member 52 31/12/09
Director/Board Member 51 -
Members of the board TitleAgeSince
Chief Executive Officer 59 28/09/00
Director/Board Member 66 31/05/14
Director/Board Member 64 28/09/00
More insiders
Date Price Change Volume
25/06/24 4.74 +1.50% 245,012
24/06/24 4.67 +0.65% 266,658
21/06/24 4.64 -0.22% 355,483
20/06/24 4.65 -0.21% 158,065
18/06/24 4.66 -0.64% 569,535

Delayed Quote OTC Markets, June 25, 2024 at 08:47 pm

More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows: - medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE; - support services to medical institutions (16.5%): - clinical trial related services (10.7%): clinical trial support and clinical trial operations management services; - human resources services (6.6%); - other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites. The balance of sales (24.3%) concerns international activities.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,532 JPY
Average target price
2,215 JPY
Spread / Average Target
+44.61%
Consensus